The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
High intensity focused ultrasound in clinical tumor ablation
Open accessAbstract
Recent advances in high intensity focused ultrasound (HIFU), which was developed in the 1940s as a viable thermal tissue ablation approach, have increased its popularity. In clinics, HIFU has been applied to treat a variety of solid malignant tumors in a well-defined volume, including the pancreas, liver, prostate, breast, uterine fibroids, and soft-tissue sarcomas. In comparison to conventional tumor/cancer treatment modalities, such as open surgery, radio- and chemo-therapy, HIFU has the advantages of non-invasion, non-ionization, and fewer complications after treatment. Over 100 000 cases have been treated throughout the world with great success. The fundamental principles of HIFU ablation are coagulative thermal necrosis due to the absorption of ultrasound energy during transmission in tissue and the induced cavitation damage. This paper reviews the clinical outcomes of HIFU ablation for applicable cancers, and then summarizes the recommendations for a satisfactory HIFU treatment according to clinical experience. In addition, the current challenges in HIFU for engineers and physicians are also included. More recent horizons have broadened the application of HIFU in tumor treatment, such as HIFU-mediated drug delivery, vessel occlusion, and soft tissue erosion ("histotripsy"). In summary, HIFU is likely to play a significant role in the future oncology practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Estimates of the worldwide incidence of eighteen major cancers in 1985
Parkin, D. M., Pisani, P., & Ferlay, J. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540413 · Cited by 1,638
Noninvasive MR Imaging–guided Focal Opening of the Blood-Brain Barrier in Rabbits
Hynynen, K., McDannold, N., Vykhodtseva, N., & Jolesz, F. A. (2001) · Radiology · doi:10.1148/radiol.2202001804 · Cited by 1,456
High-intensity focused ultrasound in the treatment of solid tumours
Kennedy, J. E. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1591 · Cited by 1,282
High intensity focused ultrasound: Physical principles and devices
ter Haar, >., & Coussios, C. (2007) · International Journal of Hyperthermia · doi:10.1080/02656730601186138 · Cited by 805
A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY
Lynn, J. G., Zwemer, R. L., Chick, A. J., & Miller, A. E. (1942) · Journal of General Physiology · doi:10.1085/jgp.26.2.179 · Cited by 690
Hynynen, K., McDannold, N., Sheikov, N. A., Jolesz, F. A., & Vykhodtseva, N. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.046 · Cited by 679
Spies, J. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01702-1 · Cited by 647
Ultrasonic drug delivery – a general review
Pitt, W. G., Husseini, G. A., & Staples, B. J. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.37 · Cited by 621
Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids
Stewart, E. A., Rabinovici, J., Tempany, C. M. C., Inbar, Y., Regan, L., Gastout, B., Hesley, G., Kim, H. S., Hengst, S., & Gedroye, W. M. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.04.072 · Cited by 480
Cited by
Zhang, S., Li, F., Jiang, X., Kim, J., Luo, J., & Geng, X. (2015) · Progress in Materials Science · doi:10.1016/j.pmatsci.2014.10.002 · Cited by 875
Izadifar, Z., Izadifar, Z., Chapman, D., & Babyn, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020460 · Cited by 457
“Heat coagulation by HIFU is desired for cell reaction with chronic inflammation, and histological signs of fat necrosis in the surrounding normal fatty tissue [9].”
BackgroundInfluentialNanoparticle-assisted ultrasound: A special focus on sonodynamic therapy against cancer
Canavese, G., Ancona, A., Racca, L., Canta, M., Dumontel, B., Barbaresco, F., Limongi, T., & Cauda, V. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.01.060 · Cited by 457
Tumor Ablation: Common Modalities and General Practices
Knavel, E. M., & Brace, C. L. (2013) · Techniques in Vascular and Interventional Radiology · doi:10.1053/j.tvir.2013.08.002 · Cited by 368
Advances and perspectives in organic sonosensitizers for sonodynamic therapy
Xing, X., Zhao, S., Xu, T., Huang, L., Zhang, Y., Lan, M., Lin, C., Zheng, X., & Wang, P. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214087 · Cited by 334
High-Intensity Focused Ultrasound: A Review of Mechanisms and Clinical Applications
Bachu, V. S., Kedda, J., Suk, I., Green, J. J., & Tyler, B. (2021) · Annals of Biomedical Engineering · doi:10.1007/s10439-021-02833-9 · Cited by 297
Neural Dust: An Ultrasonic, Low Power Solution for Chronic Brain-Machine Interfaces
Seo, D., Carmena, J. M., Rabaey, J. M., Alon, E., & Maharbiz, M. M. (2013) · arXiv · doi:10.48550/arxiv.1307.2196 · Cited by 172
Present and future of metal nanoparticles in tumor ablation therapy
Lou, W., Xie, L., Xu, L., Xu, M., Xu, F., Zhao, Q., & Jiang, T. (2023) · Nanoscale · doi:10.1039/d3nr04362b · Cited by 33
The Use of High-Intensity Focused Ultrasound for the Rewarming of Cryopreserved Biological Material
Olmo, A., Barroso, P., Barroso, F., & Risco, R. (2021) · IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control · doi:10.1109/tuffc.2020.3016950 · Cited by 20
Metadata
- Authors
- Zhou, Y.-F.
- Venue
- World Journal of Clinical Oncology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2011
- Volume
- 2
- Issue
- 1
- Pages
- 8
- ISSN
- 2218-4333 (ISSN-L)
- OpenAlex
- W2032526594
- Cited by
- 625
- References
- 59
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.